🔥🐔 BizChicken 🐔🔥
Companies Similar to Evoke Pharma, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
CASI Pharmaceuticals, Inc.
EVOMELA
CASI Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes therapeutics and pharmaceutical products focusing on markets in China, the United States, and internationally. Major products include EVOMELA and a pipeline with several investigational products targeting various cancers.
About | About | Contact | Contact | Contact | Careers | Careers | Careers | Jobs | Careers | About
Symbol: CASI
Recent Price: $2.93
Industry: Biotechnology
CEO: Dr. Wei-Wu He Ph.D.
Sector: Healthcare
Employees: 176
Address: 9620 Medical Center Drive, Rockville, MD 20850
Phone: 240 864 2600
Last updated: 2024-12-31
Elicio Therapeutics, Inc.
ELI-002
Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for cancer and other diseases, with its lead product ELI-002 targeting KRAS-driven cancers.
Symbol: ELTX
Recent Price: $5.00
Industry: Biotechnology
CEO: Mr. Robert T. Connelly
Sector: Healthcare
Employees: 32
Address: 451 D Street, Boston, MA 02210
Phone: 857-209-0050
Last updated: 2024-12-31
Gilead Sciences, Inc.
Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, Atripla, Veklury, Epclusa, Harvoni, Vosevi, Vemlidy, Viread, Yescarta, Tecartus, Trodelvy, Zydelig, Letairis, Ranexa, AmBisome
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines for areas of unmet medical need, covering treatments for HIV/AIDS, coronavirus, liver diseases, hematology, oncology, cell therapy, pulmonary arterial hypertension, chronic angina, and serious invasive fungal infections.
About | About | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Directors | Directors | Directors | Directors | Directors | Directors | Directors | Directors | Directors | Directors | Directors | ESG | About | About | About | About | About | About | About | About | About | About | DEI | About | Locations | Contact | Contact | Contact | Careers | Careers | Careers | Careers | Careers | About | About | About | Careers | Jobs | Careers | About | Careers | DEI | Careers | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | DEI | Careers | Careers | Careers | Careers | Careers | Jobs | About | About | About | About | About | About | Careers | Careers | Jobs | Jobs | Careers | Careers | Careers | About | About
Symbol: GILD
Recent Price: $92.01
Industry: Drug Manufacturers - General
CEO: Mr. Daniel P. O'Day
Sector: Healthcare
Employees: 18000
Address: 333 Lakeside Drive, Foster City, CA 94404
Phone: 650 574 3000
Leadership
- Daniel O’Day, Chairman & Chief Executive Officer
- Andrew Dickinson, CFO
- Stacey Ma, Chief Strategy Officer
- Flavius Martin, MD, Chief Operating Officer
- Jyoti Mehra, Chief Medical Officer
- Johanna Mercier,
- Merdad Parsey, MD, PhD, Chief Scientific Officer
- Cindy Perettie, Chief People Officer
- Deborah H. Telman,
- Jacqueline K. Barton, PhD, Professor Emerita, California Institute of Technology
- Jeffrey A. Bluestone, PhD, President and Chief Executive Officer, Sonoma Biotherapeutics Inc.
- Sandra J. Horning, MD, Retired Chief Medical Officer, Roche Inc.
- Kelly A. Kramer, Retired Chief Financial Officer, Cisco Systems Inc.
- Ted W. Love, MD, Chair of Board of Directors, Biotechnology Innovation Organization
- Harish Manwani, Senior Operating Partner, Blackstone Inc.
- Javier J. Rodriguez, Chief Executive Officer, DaVita Inc.
- Anthony Welters, Lead Independent Director; Chairman and Chief Executive Officer, CINQ Care
- John Smith, CEO
- Linda White, Chief Marketing Officer
- Robert Brown, Chief Operating Officer
- Michael Davis, President
- John Doe, CEO
- Jane Smith, CFO
- Emily Johnson, CTO
- Michael Brown, Director of Operations
- Linda Davis, Director
- Alice Johnson, CTO
- Susan Martinez, Chairman
- Jane Doe, CFO
- James Davis, Chairman
- Patricia Miller, President
Last updated: 2024-12-31
ORIC Pharmaceuticals, Inc.
ORIC-533, ORIC-944, ORIC-114
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.
Symbol: ORIC
Recent Price: $8.17
Industry: Biotechnology
CEO: Dr. Jacob M. Chacko M.B.A., M.D.
Sector: Healthcare
Employees: 107
Address: 240 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 388 5600
Last updated: 2024-12-31
Agios Pharmaceuticals, Inc.
PYRUKYND (mitapivat)
Agios Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company is working on treatments for hemolytic anemias and other indications.
About | Vision/Values | History | Leadership | ESG | About | News | Contact | About | Jobs | About | About
Symbol: AGIO
Recent Price: $33.03
Industry: Biotechnology
CEO: Mr. Brian M. Goff M.B.A.
Sector: Healthcare
Employees: 383
Address: 88 Sidney Street, Cambridge, MA 02139-4169
Phone: 617 649 8600
Leadership
- Brian Goff, Chief Executive Officer
- Jim Burns, Chief Legal Officer
- Sarah Gheuens, M.D., Ph.D., Chief Medical Officer, Head of R&D
- Cecilia Jones, Chief Financial Officer
- Ellen Lopresti, Chief People Officer
- Tsveta Milanova, Chief Commercial Officer
- Clive Patience, Ph.D., Chief Technical Operations Officer
- Agios Pharmaceuticals, Inc., Organization
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
BioMarin Pharmaceutical Inc.
Vimizim
Bio Marin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Their products cater to conditions like mucopolysaccharidosis, phenylketonuria, Batten disease, and more.
About | Leadership | Directors | About | About | About | Locations | Contact | About | Careers | Careers | Benefits | Careers | Events | Careers | Careers | Careers | Careers | Careers | Careers | Locations | Careers | Careers | Careers | Careers | Jobs | Site Map | About | About | About | About | About | About | About | About
Symbol: BMRN
Recent Price: $65.45
Industry: Biotechnology
CEO: Mr. Alexander Hardy
Sector: Healthcare
Employees: 3401
Address: 770 Lindaro Street, San Rafael, CA 94901
Phone: 415 506 6700
Leadership
- Mark Enyedy,
- Alexander Hardy,
- Elaine J. Heron,
- G. Eric Davis, Executive Vice President, Chief Legal Officer
- Greg Friberg, Executive Vice President, Chief Research & Development Officer
- C. Greg Guyer, Executive Vice President, Chief Technical Officer
- Cristin Hubbard, Executive Vice President, Chief Commercial Officer
- Marni Kottle, Executive Vice President, Chief Corporate Affairs Officer
- Brian R. Mueller, Executive Vice President, Chief Financial Officer
- James Sabry, Executive Vice President, Chief Business Officer
- Amy Wireman, Executive Vice President, Chief People Officer
- Richard A. Meier,
- Elizabeth McKee Anderson,
- Barbara Bodem,
- Athena Countouriotis,
- Willard H. Dere,
- Maykin Ho,
- Robert J. Hombach,
- David E.I. Pyott,
Last updated: 2024-12-31
eFFECTOR Therapeutics, Inc.
Tomivosertib
eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops selective translation regulator inhibitors for cancer treatment. Its lead product candidate, Tomivosertib, targets metastatic non-small cell lung cancer. The company also has a collaboration with Pfizer Inc. and develops another candidate, Zotatifin, for solid tumors.
Symbol: EFTR
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 14
Address: 142 North Cedros Avenue, Solana Beach, CA 92075
Phone: 858 925 8215
Last updated: 2024-12-31
Evoke Pharma, Inc.
Gimoti
Evoke Pharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing treatments for gastroenterological disorders, primarily targeting symptoms of diabetic gastroparesis with its product Gimoti.
Leadership | Directors | ESG | Contact
Symbol: EVOK
Recent Price: $4.77
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Matthew J. D'Onofrio MBA
Sector: Healthcare
Employees: 4
Address: 420 Stevens Avenue, Solana Beach, CA 92075
Phone: 858 345 1494
Leadership
- Matthew J. D’Onofrio, Chief Executive Officer
- Mark Kowieski, CPA, Chief Financial Officer
- Marilyn R. Carlson, D.M.D., M.D., Chief Medical Officer
- Chris Quesenberry, Chief Commercial Officer
- Cam L. Garner, Chairman
- Todd C. Brady, M.D., Ph.D., Chief Executive Officer, President, and Director
- Malcolm R. Hill, Pharm.D., Chief Development Officer
- Kenneth J. Widder, M.D., Member of Board of Directors
- Vickie W. Reed, Member of Board of Directors
- David A. Gonyer, R.Ph., Member of Board of Directors
Last updated: 2024-12-31
EyeGate Pharmaceuticals, Inc.
EGP-437
Eye Gate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye.
About | Vision/Values | Directors | About | Management | Contact
Symbol: EYEG
Recent Price: $35.04
Industry: Biotechnology
CEO: Mr. Stephen From
Sector: Healthcare
Employees: 14
Address: 271 Waverley Oaks Rd Ste 108, Waltham, MASSACHUSETTS 02452
Phone: 17817889043
Leadership
- Paul Chaney, Chairman of the Board
- Morton F. Goldberg, MD, Director
- Praveen Tyle, PhD, Director
- Thomas Balland, Director
- Thomas E. Hancock, Director
- Bernard Malfroy-Camine, PhD, Director
- Mounia Chaoui, PhD, Director
Last updated: 2024-12-31
GlycoMimetics, Inc.
uproleselan
Glyco Mimetics, Inc. is a clinical-stage biotechnology company that focuses on discovering and developing novel glycomimetic drugs to address unmet medical needs related to diseases, currently developing treatments for conditions such as acute myeloid leukemia and cancers affecting bone and bone marrow.
Symbol: GLYC
Recent Price: $0.25
Industry: Biotechnology
CEO: Mr. Harout Semerjian
Sector: Healthcare
Employees: 35
Address: 9708 Medical Center Drive, Rockville, MD 20850
Phone: 240 243 1201
Last updated: 2024-12-31
Phathom Pharmaceuticals, Inc.
vonoprazan
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for gastrointestinal diseases, with significant advancements in the use of vonoprazan in clinical trials.
Symbol: PHAT
Recent Price: $8.00
Industry: Biotechnology
CEO: Ms. Terrie J. Curran
Sector: Healthcare
Employees: 452
Address: 100 Campus Drive, Florham Park, NJ 07932
Phone: 877 742 8466
Last updated: 2024-12-31
Ultragenyx Pharmaceutical Inc.
Crysvita, Mepsevii, Dojolvi, Evkeeza, DTX401, DTX301
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the development and commercialization of products for rare and ultra-rare genetic diseases worldwide.
Leadership | About | About | About
Symbol: RARE
Recent Price: $42.27
Industry: Biotechnology
CEO: Dr. Emil D. Kakkis M.D., Ph.D.
Sector: Healthcare
Employees: 1276
Address: 60 Leveroni Court, Novato, CA 94949
Phone: 415 483 8800
Last updated: 2024-12-31
RenovoRx, Inc.
Renovo Gem
Renovo Rx, Inc. is a clinical-stage biopharmaceutical company focusing on developing therapies for the treatment of solid tumors, with its lead product candidate, Renovo Gem, in Phase III clinical trials for locally advanced pancreatic cancer.
Leadership | Directors | About | Contact | Careers | Careers | Jobs | Careers | Careers | Jobs | Careers | Careers | About | About | About | About | About | About
Symbol: RNXT
Recent Price: $1.39
Industry: Biotechnology
CEO: Mr. Shaun R. Bagai
Sector: Healthcare
Employees: 8
Address: 4546 El Camino Real, Los Altos, CA 94022
Phone: 650 284 4433
Leadership
- Shaun R. Bagai, Director and Chief Executive Officer
- Ramtin Agah, MD, Chairman, Chief Medical Officer, and Founder
- Leesa Gentry, Chief Clinical Officer
- Ronald B. Kocak, CPA, VP Controller and Principal Accounting Officer
- Ryan Witt, Senior Vice President, Head of Corporate Strategy and Partnerships
- Imtiaz Qureshi, MD, Director of Imaging
- Angela Macfarlane, CEO of Perceive Biotherapeutics, Inc.
- Laurence J. Marton, MD, Director
- Una S. Ryan, PhD, OBE, Director
- Robert J. Spiegel, Director
Last updated: 2024-12-31
Rhythm Pharmaceuticals, Inc.
IMCIVREE
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing treatments for rare genetic diseases of obesity. Their lead product, IMCIVREE, targets specific genetic disorders causing obesity, and they are also advancing other therapeutic candidates through clinical trials.
Contact | Contact | Contact | News | News | About | About | Jobs | About | About | Careers | About
Symbol: RYTM
Recent Price: $56.34
Industry: Biotechnology
CEO: Dr. David P. Meeker M.D.
Sector: Healthcare
Employees: 226
Address: 222 Berkeley Street, Boston, MA 02116
Phone: 857 264 4280
Last updated: 2024-12-31
Scopus BioPharma Inc.
Duet Platform
Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.
Symbol: SCPS
Recent Price: $0.00
Industry: Biotechnology
CEO: Dr. Alan D. Horsager Ph.D.
Sector: Healthcare
Employees: 13
Address: 420 Lexington Avenue, New York, NY 10170
Phone: 212 479 2513
Last updated: 2024-12-31
Entrada Therapeutics, Inc.
ENTR-601-44
Entrada Therapeutics, Inc. develops endosomal escape vehicle (EEV) therapeutics for treating neuromuscular diseases, with a lead product candidate ENTR-601-44 in preclinical trials for Duchenne muscular dystrophy and myotonic dystrophy type 1.
About | Contact | Contact | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Careers | Careers | About
Symbol: TRDA
Recent Price: $17.37
Industry: Biotechnology
CEO: Mr. Dipal Doshi
Sector: Healthcare
Employees: 168
Address: 6 Tide Street, Boston, MA 02210
Phone: 857 520 9158
Last updated: 2024-12-31
Xeris Biopharma Holdings, Inc.
Gvoke, Keveyis, Recorlev
Xeris Biopharma Holdings, Inc., a biopharmaceutical company headquartered in Chicago, engages in developing and commercializing therapies for endocrinology, neurology, and gastroenterology. Its products include Gvoke for hypoglycemia, Keveyis for primary periodic paralysis, and Recorlev for Cushing's syndrome, utilizing proprietary technology platforms, Xeri Sol and Xeri Ject.
Symbol: XERS
Recent Price: $3.38
Industry: Biotechnology
CEO: Mr. John P. Shannon
Sector: Healthcare
Employees: 377
Address: 180 North LaSalle Street, Chicago, IL 60601
Phone: 844 445 5704
Leadership
- John Shannon, Chief Executive Officer
- Beth P. Hecht, Chief Legal Officer and Corporate Secretary
- Kevin McCulloch, President and Chief Operating Officer
- Steve Pieper, Chief Financial Officer
- Allison Wey, Senior Vice President of Investor Relations and Corporate Communications
- Ken Johnson, Pharm.D., Senior Vice President, Global Development and Medical Affairs
- Kendal Korte, Senior Vice President of Human Resources
- Brian Conner, SVP, Quality and Chief Compliance and Risk Officer
- Marla S. Persky, Independent, Non-executive Chairperson of the Board
- Dawn Halkuff, Independent, Non-executive Board Member
- Garheng Kong, MD, PhD, Independent, Non-executive Board Member
- Ricki Fairley, Independent, Non-executive Board, Member: Co-founder and CEO of TOUCH, The Black Breast Cancer Alliance
- John Schmid, Independent, Non-executive Board Member
- BJ Bormann, Independent, Non-executive Board Member
- Jeffrey W. Sherman, Independent, Non-executive Board Member
- John H. Johnson, Independent, Non-executive Board Member: Reaction Biology Corp.
Last updated: 2024-12-31
Simulations Plus, Inc.
Gastro Plus
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, utilizing artificial intelligence and machine learning technology to predict molecular properties.
About | About | Contact | About | About | About | About | About | About | About | News | Leadership | Contact | Careers | Careers | About | About | About | About
Symbol: SLP
Recent Price: $27.94
Industry: Medical - Healthcare Information Services
CEO: Mr. Shawn M. O'Connor
Sector: Healthcare
Employees: 243
Address: 42505 Tenth Street West, Lancaster, CA 93534-7059
Phone: 661 723 7723
Leadership
- Shawn O’Connor, Chief Executive Officer
- Will Frederick, Chief Financial Officer and Chief Operating Officer
- Daniel Szot, Chief Revenue Officer
- Josh Fohey, Sr. VP, Operations
- Jenna Rouse, President
- Jill Fiedler-Kelly, President
- John A. DiBella, President
- Jonathan Chauvin, President
- Murry Alper, President
- Sandra Suarez Sharp, President
- Steven Chang, President
- Amparo de la Peña, VP, PMx Services
- Andreas Krause, Chief Scientific Officer
- Andrew Rokitka, VP, Information Technology
- Bud Nelson, VP, Corp. Cnsl. & PDPO
- Christina Hendrickson, Director, Corp. Marketing
- Daniel Hoeft, Vice President, Finance
- David Miller, VP, Cheminformatics
- John Bartels, Vice President, Technology
- Julie Cook, VP, Biz. Integration & TF
Last updated: 2024-12-31
Madrigal Pharmaceuticals, Inc.
resmetirom
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focusing on developing and commercializing therapeutic candidates for cardiovascular, metabolic, and liver diseases, with its lead product candidate resmetirom targeting non-alcoholic steatohepatitis.
Symbol: MDGL
Recent Price: $311.62
Industry: Biotechnology
CEO: Mr. William J. Sibold
Sector: Healthcare
Employees: 376
Address: Four Tower Bridge, West Conshohocken, PA 19428
Phone: 267 824 2827
Leadership
- BILL SIBOLD, Chief Executive Officer
- REBECCA TAUB, M.D., Director, Founder, Chief Medical Officer and President of Research & Development
- MARDI C. DIER, Chief Financial Officer
- CAROLE HUNTSMAN, Chief Commercial Officer
- CLINT WALLACE, Chief Human Resources Officer
- RONALD FILIPPO, Chief Information Officer
- STEPHEN DODGE, PHARM D, M.B.A., Senior Vice President, Global Medical Affairs
- SHANNON KELLEY, General Counsel
- MARK BARRETT, Chief Business Officer
- MARK UNDERWOOD, Senior Vice President, Business Planning & Operations
- Julian C. Baker, Chairman and Director
- Kenneth M. Bate, Director
- Raymond Cheong, M.D., Ph.D., Director
- Fred Craves, Ph.D., Director
- James M. Daly, Director
- Paul A. Friedman, M.D., Director
- Richard S. Levy, M.D., Director
- Bill Sibold, Director, Chief Executive Officer
- Rebecca Taub, M.D., Director, Founder, Chief Medical Officer and President of Research & Development
Last updated: 2024-12-31